Healius Limited (ASX:HLS)
Australia flag Australia · Delayed Price · Currency is AUD
0.8670
-0.0030 (-0.34%)
Nov 7, 2025, 10:36 AM AEST

Healius Company Description

Healius Limited provides medical laboratory and pathology services in Australia.

The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands.

It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018.

Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Healius Limited
CountryAustralia
Founded1994
IndustryDiagnostics & Research
SectorHealthcare
Employees8,224
CEOPaul Anderson

Contact Details

Address:
161 Castlereagh Street
Sydney, Victoria 2000
Australia
Phone61 2 9432 9400
Websitehealius.com.au

Stock Details

Ticker SymbolHLS
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000033359
SIC Code8011

Key Executives

NamePosition
Paul D. Anderson B.Com., C.A.MD, Chief Executive Officer and Director
Puneet Nagi M.B.A.Chief Operating Officer
Prasad AravGroup Executive of Digital and Technology and Strategy
Sharon NgHead of FP&A and Investor Relations
Kylie BrownGroup General Counsel, Company Secretary and Chief Risk Officer
Paula BaylissGroup Executive of People and Culture
John McKechnieAdvisor
Dr. Phil LucasChief Executive of Lumus Imaging
Ian McphanChief Operating Officer of Healius Pathology
Dr. Jan Van RooyenHead and Group Executive of Healius Pathology